EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis

Gopalkumar Rakesh, Patrick Cordero, Rebika Khanal, Seth S Himelhoch, Craig R Rush

Journal of Affective Disorders · 2024-08 · 358 · 432-439

DOI: 10.1016/j.jad.2024.05.037 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Affective Disorders, 2024-08. Verfasst von Gopalkumar Rakesh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, College of Medicine, University of Kentucky, Lexington, KY, United States of America. Electronic address: gopalkumar.rakesh…. Hauptthemen laut MEDLINE: Antidepressive Agents, Major Depressive Disorder, Transcranial Magnetic Stimulation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a critical knowledge gap in optimally combining transcranial magnetic stimulation (TMS) and antidepressants to treat patients with major depressive disorder (MDD). TMS is effective in treating MDD in patients who have failed at least one antidepressant trial, with accelerated protocols showing faster remission in treatment-resistant depression (TRD). Although clinicians routinely augment antidepressants with TMS, there is a knowledge gap in stopping versus continuing antidepressants or the dosing strategies when starting or tapering TMS. These considerations are important when considering maintenance TMS (delivered alone or in combination with suitable antidepressants) to maintain remission in MDD after the index course of TMS. As the first step towards filling this knowledge gap, we reviewed randomized controlled trials (RCTs) and open-label trials from 2 databases (PubMed/Medline and EMBASE) that compared active TMS combined with a pre-specified antidepressant dosed in the same manner for adults with MDD versus sham TMS combined with the same antidepressant as in the active arm. All studies were published between January 1, 2000, and December 31, 2023. We excluded case reports, case series, and clinical studies that augmented TMS with antidepressants and vice versa. We found 10 RCTs (n = 654 participants) and performed a meta-analysis. This showed active TMS combined with pre-specified antidepressants had greater efficacy for MDD treatment than sham TMS combined with the same antidepressants as in the active arm (Hedge's g = 1; 95 % CI [0.27, 1.73]). The review and meta-analysis indicate greater short-term efficacy in combining antidepressants with TMS from the get-go in MDD. Given the increasing role of accelerated TMS protocols in expediting remission in MDD and the results of our meta-analysis, we advocate for RCTs examining the short-term and long-term effects of various antidepressant classes on these TMS protocols in MDD. This can also optimize and individualize maintenance TMS protocols to prevent relapse in MDD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsMajor Depressive DisorderTranscranial Magnetic StimulationHumansCombined Modality TherapyDepressive Disorder, Treatment-ResistantRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

AntidepressantsMajor depressive disorder (MDD)Transcranial magnetic stimulation (TMS)

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Psychiatry, College of Medicine, University of Kentucky, Lexington, KY, United States of America. Electronic address: gopalkumar.rakesh@uky.edu.
  • Department of Psychiatry and Behavioral Health, The Ohio State University College of Medicine, Columbus, OH, United States of America.
  • University of Kentucky College of Medicine, Lexington, KY, United States of America.
  • Department of Psychiatry, College of Medicine, University of Kentucky, Lexington, KY, United States of America.
  • Department of Behavioral Sciences, College of Medicine, University of Kentucky, Lexington, KY, United States of America.

Förderung

  • NIAAA NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Rakesh, G., Cordero, P., Khanal, R., Himelhoch, S. S., & Rush, C. R. (2024). Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis. Journal of Affective Disorders, 358, 432-439. https://doi.org/10.1016/j.jad.2024.05.037

Vancouver

Rakesh G, Cordero P, Khanal R, Himelhoch SS, Rush CR. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis. Journal of Affective Disorders. 2024;358:432-439. doi:10.1016/j.jad.2024.05.037

BibTeX
@article{Rakesh2024,
  author = {Rakesh, Gopalkumar and Cordero, Patrick and Khanal, Rebika and Himelhoch, Seth S and Rush, Craig R},
  title = {Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis},
  journal = {Journal of Affective Disorders},
  year = {2024},
  volume = {358},
  pages = {432--439},
  doi = {10.1016/j.jad.2024.05.037}
}
Kostenlos starten →